Price T Rowe Associates Inc Vera Therapeutics, Inc. Transaction History
Price T Rowe Associates Inc
- $812 Billion
- Q1 2025
A detailed history of Price T Rowe Associates Inc transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 4,754,832 shares of VERA stock, worth $101 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,754,832
Previous 4,377,049
8.63%
Holding current value
$101 Million
Previous $185 Million
38.3%
% of portfolio
0.01%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding VERA
# of Institutions
196Shares Held
63.9MCall Options Held
723KPut Options Held
186K-
Avoro Capital Advisors LLC New York, NY5.7MShares$121 Million2.22% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$70.9 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$62.8 Million19.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.92MShares$62 Million0.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.79MShares$59.3 Million4.94% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $574M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...